Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients

Detalles Bibliográficos
Autores principales: Gonzalez-Serna, Alejandro, Genebat, Miguel, Ruiz-Mateos, Ezequiel, Leal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723024/
https://www.ncbi.nlm.nih.gov/pubmed/26848259
http://dx.doi.org/10.2147/DDDT.S100639
_version_ 1782411443876921344
author Gonzalez-Serna, Alejandro
Genebat, Miguel
Ruiz-Mateos, Ezequiel
Leal, Manuel
author_facet Gonzalez-Serna, Alejandro
Genebat, Miguel
Ruiz-Mateos, Ezequiel
Leal, Manuel
author_sort Gonzalez-Serna, Alejandro
collection PubMed
description
format Online
Article
Text
id pubmed-4723024
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47230242016-02-04 Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients Gonzalez-Serna, Alejandro Genebat, Miguel Ruiz-Mateos, Ezequiel Leal, Manuel Drug Des Devel Ther Letter Dove Medical Press 2016-01-18 /pmc/articles/PMC4723024/ /pubmed/26848259 http://dx.doi.org/10.2147/DDDT.S100639 Text en © 2016 Gonzalez-Serna et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed
spellingShingle Letter
Gonzalez-Serna, Alejandro
Genebat, Miguel
Ruiz-Mateos, Ezequiel
Leal, Manuel
Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
title Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
title_full Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
title_fullStr Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
title_full_unstemmed Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
title_short Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
title_sort short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in hiv-1-infected treatment-naïve patients
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723024/
https://www.ncbi.nlm.nih.gov/pubmed/26848259
http://dx.doi.org/10.2147/DDDT.S100639
work_keys_str_mv AT gonzalezsernaalejandro shorttermmaravirocexposureaclinicalapproachtodecideonmaravirocprescriptioninhiv1infectedtreatmentnaivepatients
AT genebatmiguel shorttermmaravirocexposureaclinicalapproachtodecideonmaravirocprescriptioninhiv1infectedtreatmentnaivepatients
AT ruizmateosezequiel shorttermmaravirocexposureaclinicalapproachtodecideonmaravirocprescriptioninhiv1infectedtreatmentnaivepatients
AT lealmanuel shorttermmaravirocexposureaclinicalapproachtodecideonmaravirocprescriptioninhiv1infectedtreatmentnaivepatients

Ejemplares similares